Vimian Group AB (publ) (STO:VIMIAN)

Sweden flag Sweden · Delayed Price · Currency is SEK
42.60
+0.86 (2.06%)
May 28, 2025, 12:59 PM CET
26.79%
Market Cap 22.32B
Revenue (ttm) 4.24B
Net Income (ttm) 209.39M
Shares Out 523.89M
EPS (ttm) 0.40
PE Ratio 105.90
Forward PE 33.14
Dividend n/a
Ex-Dividend Date n/a
Volume 119,215
Average Volume 243,463
Open 41.02
Previous Close 41.74
Day's Range 41.02 - 42.66
52-Week Range 31.45 - 47.30
Beta 1.51
RSI 60.49
Earnings Date Jul 18, 2025

About Vimian Group AB

Vimian Group AB (publ) engages in the animal health business worldwide. It operates through Specialty Pharma, MedTech, Diagnostics, and Veterinary Services segments. The company offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals under the Nextmune brand name; and molecular and immunodiagnostic solutions that are used by laboratories for veterinary specific applications with a focus on livestock and companion animal health markets under the I... [Read more]

Sector Healthcare
Founded 2020
Employees 1,200
Stock Exchange Nasdaq Stockholm
Ticker Symbol VIMIAN
Full Company Profile

Financial Performance

In 2024, Vimian Group AB's revenue was 374.80 million, an increase of 12.99% compared to the previous year's 331.70 million. Earnings were 18.50 million, an increase of 88.78%.

Financial numbers in EUR Financial Statements

News

There is no news available yet.